The eClinical Solutions Market size was valued at USD 12.20 Billion in 2023 and the total EClinical Solutions revenue is expected to grow at a CAGR of 12.69 % from 2024 to 2030, reaching nearly USD 20.75 Billion by 2030. Global eClinical Solutions Market Overview The recently published “Global eClinical Solutions Market” Report by Maximize Market Research is available in...

AI in Clinical Trials Market Overview: The "Global AI in Clinical Trials Market Analysis" explores the AI in Clinical Trials Industry in great detail, focusing on extensive analysis and global market trends. The purpose of this study is to provide a thorough market segmentation by segment and geography in addition to an overview of the AI in Clinical Trials industry. The research...

According to FutureWise analysis the market for AI-based clinical trials solution provider in 2023 is US$ 1.96 billion, and is expected to reach US$ 9.74 billion by 2031 at a CAGR of 22.20%. The integration of AI-based technologies in preclinical and clinical studies is becoming increasingly prevalent, transforming the landscape of drug development and research. These advanced tools present...

Emergen research’s latest document, titled ‘AI-based Clinical Trials Solution Provider Market’ is one of the most sought-after market reports involving an in-depth analysis of the global AI-based Clinical Trials Solution Provider Market. The report’s authors have offered necessary details on the latest AI-based Clinical Trials Solution Provider Market trends and the...

AI-based Clinical Trials Solution Provider Industry The global AI-based clinical trials solution provider market size is expected to reach USD 7.8 billion by 2030, registering a CAGR of 22.1% during the forecast period, according to a new report by Grand View Research, Inc.. AI is a versatile tool and is being increasingly utilized to improve the operational efficacy of drug studies...

The global acne drugs market size is expected to reach USD 13.13 billion by 2030, according to a new report by Grand View Research, Inc., registering a 5.2% CAGR from 2024 to 2030. Several factors such as emergence of biologics, unhealthy lifestyle, and rising disease incidence are anticipated to drive the market. Acne vulgaris is one of the most common dermatological disorders,...

The global anti-infective agents market size is estimated to reach USD 144.96 billion by 2030, expanding at a CAGR of 1.61% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of infectious diseases such as HIV, H1N1, and Ebola virus reflect the profound changes in behavioral patterns of communities over the recent decades. The societal...

The global BFS (blow-fill-seal) product market size was USD 374.4 Million in 2021 and is expected to register a revenue CAGR of 5.9% over the forecast period, according to the latest report by Reports and Data. New drug-ready technologies in various stages of development offer new options for pre-filled syringes, as they will be able to administer drugs with higher fill volumes and...

Clinical Trial Supplies Industry Overview   The global clinical trial supplies market size was estimated at USD 2.58 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. Globalization, and rise in the number of biologics & biosimilar drugs in clinical trials are among the major factors...

The global cancer immunotherapy market is set to garner US$ 159.2 billion in revenue in 2024, according to Fact.MR, a market research and intelligence provider. Worldwide demand for cancer immunotherapies is projected to increase at a CAGR of 10% and reach a market value of US$ 412.8 billion by 2034.This unprecedented growth presents a unique opportunity for manufacturers and market payers to...